Navigation Links
Portola Pharmaceuticals Announces Positive Phase II EXPERT Results,and Additional Oral and Poster Presentations at the XXI Congress of,the International Society on Thrombosis and Haemostasis (ISTH)

SOUTH SAN FRANCISCO, July 02, 2007 /PRNewswire/ -- Portola Pharmaceuticals, Inc. announced today that it will present clinical and preclinical data on its oral Factor Xa inhibitor and on its intravenous and oral ADP receptor antagonist at the XXI Congress of the International Society of Thrombosis and Haemostasis (ISTH) in Geneva, Switzerland on July 6 through July 12, 2007.

The EXPERT poster, which outlines Phase II data on the Company's lead compound PRT054021, is entitled "Evaluation of the Factor Xa (FXA) Inhibitor, PRT054021 (PRT021), against Enoxaparin in Randomized Trial for the Prevention of Venous Thromboembolic Events after Total Knee Replacement (EXPERT)" and will be featured on July 10, 2007 at 5:30 p.m. CEST in the exhibition area.

    In addition, Portola will make the following presentations:


     "Initial Intravenous Experience with PRT060128 (PRT128), an Orally-

     Available, Direct-Acting, and Reversible P2Y12 Inhibitor," July 10 at

     5:30 p.m. (CEST) in the exhibition area.


     "PRT060128, A Novel, Direct-Acting Orally Available P2Y12 Antagonist,

     Confers Superior Antithrombotic Activity over Clopidogrel in a Mouse

     Thrombosis Model," July 11 at 10:00 a.m. (CEST) in Room Mont Blanc.


     "Differential Effects of Anti-Platelet Drugs on Thrombus Formation and

     Thrombus Stability," July 11, 2007 at 10:45 a.m. (CEST) in Room Mont

     Blanc.


     "Antagonism of Intrinsic Pathway Inhibits Tissue Factor (TF) -- Initiated

     Coagulation in a Platelet-Dependent Whole Blood Flow Assay" July 11 at

     5:30 p.m. (CEST) in the exhibition area.


     "Measurement of Thrombus Stability Predicts Coronary Events Post-

     Percutaneous Coronary Intervention (PCI)" will be presented on July 11 at

     5:30 p.m. (CEST) in the exhibition area.

About PRT054021 -- Portola's Factor Xa Inhibitor

PRT054021 is an oral Factor Xa inhibitor, an a
'"/>




Page: 1 2 3

Related medicine technology :

1. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Portola Pharmaceuticals Announces Positive Phase II Results for PRT054021 for Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery
3. Portola Pharmaceuticals Presents Positive Phase I Data of Its ADP Receptor Antagonist at the American College of Cardiology
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
Post Your Comments:
(Date:4/17/2015)... April 17, 2015 LifeScienceIndustryResearch.com ... Research Report on Global and China Lysine Industry ... a professional and the deep research report in ... Lysine basic information including definition, classification specifications, application, ... US, Europe , ...
(Date:4/17/2015)... 17, 2015 CVS Health Corporation (NYSE: ... Friday, May 1, 2015, at 8:30 a.m. (EDT) with ... results. An audio webcast of the conference ... portion of the CVS Health website for all interested ... This webcast will be archived and available on the ...
(Date:4/17/2015)... , April 17, 2015  Trovagene, Inc., ... announced today that clinical data presented at the ... its urine-based Precision Cancer Monitoring ℠ (PCM) ... monitoring of EGFR T790M mutations in ... Detection of EGFR T790M Mutation in Urinary Circulating ...
Breaking Medicine Technology:Lysine Market International (US, Europe, Japan) Research Analysis 2Lysine Market International (US, Europe, Japan) Research Analysis 3Lysine Market International (US, Europe, Japan) Research Analysis 4Lysine Market International (US, Europe, Japan) Research Analysis 5Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4
... 2011 Visionary Pharmaceuticals, Inc., announced today that ... a consortium of Angel Investors. The company is ... retinoic acid related orphan receptor (ROR) modulators targeting ... disorders including rheumatoid arthritis, multiple sclerosis, psoriasis and ...
... Ind., July 26, 2011 Symmetry Medical Inc. (NYSE: ... the global orthopaedic device industry and other medical markets, announced ... for the period ending July 2, 2011 before the market ... an accompanying conference call at 8:00 a.m. ET on Thursday, ...
Cached Medicine Technology:Visionary Pharmaceuticals, Inc., Announces Initial Seed Round Investments and the Launch of TH17 Autoimmune Disease Research Activities 2Symmetry Medical to Report Second Quarter 2011 Financial Results on August 4, 2011 2
(Date:4/18/2015)... 18, 2015 Carinsurancesavings.biz has released a ... are cheaper during Spring. , Spring can ... plan. Drivers should make sure they compare the newest ... Clients can learn more about Spring car insurance offers ... Auto insurance quotes are becoming more and more popular. ...
(Date:4/18/2015)... YORK (PRWEB) April 18, 2015 Review ... are hosting a ‘Strategies for Success’ program for cataract ... Surgeons meeting in San Diego, where eye surgeon Jeffrey ... for this invitation-only event. Dr. Martin is the Managing ... Review of Ophthalmology chose Dr. Martin to lead this ...
(Date:4/18/2015)... NC (PRWEB) April 18, 2015 Patients ... risk of developing mesothelioma later in life, but the ... from mesothelioma that is unrelated to radiation. Surviving Mesothelioma ... on its website. Click here to read it ... Australia compared the cases of 45 patients who had ...
(Date:4/18/2015)... New York, NY (PRWEB) April 18, 2015 ... their Internal Security Threat Report , which they say, “exposes ... on how many new malware variants were introduced in 2014 ... it took for Zero Day threats to be identified and ... – it is abundantly clear that doing business in a ...
(Date:4/18/2015)... Montreal, Canada (PRWEB) April 18, 2015 ... of emotions on food choices when he uttered, “Tell ... what you are.” Using food to cope with stress ... research by Queendom.com indicates otherwise. Data collected ... both genders fall victim to emotional eating, but for ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6
... Annual Conference, WASHINGTON, Oct. 11 ... Improving Healthcare Quality through Information,and Information Technology ... awards dinner for demonstrating leadership and excellence ... exchange to,drive improvements in the quality, safety ...
... Oct. 11 Global Med Technologies(R),Inc. (OTC ... technology company, today reported that its Wyndgate,Technologies(R) ... at the AABB,Annual Meeting and Transfusion Medicine ... The AABB, founded in 1947, is ...
... say , THURSDAY, Oct. 11 (HealthDay News) -- British researchers ... doctors early warning of lung cancer. , A team at ... different types of lung cancer and 50 others who were ... system proteins that are directed at the body,s own tissues ...
... Ltd. - (SWX: ORIDN) introduces Smart Capnography(TM), ... This new launch takes place at ... Francisco, CA. Smart Capnography combines Oridion,s ... software for improved alarm management.,Microstream allows the ...
... - Potential misuse of these infant medicines, not product safety, is ... driving the voluntary withdrawal,- This withdrawal does not affect cough and cold ... ... and cold medicines for infants and,children will occur at the October 18 and 19 ...
... Oct. 11 Businesses can no longer afford ... spend more than,75 billion dollars on obesity-attributable health ... are lost to obesity-related illness each,year(2). Other costs ... and high turnover rates. Today, business leaders, ...
Cached Medicine News:Health News:Inaugural eHealth Initiative Awards Honor Leadership in Health Care Quality Through Health IT 2Health News:Inaugural eHealth Initiative Awards Honor Leadership in Health Care Quality Through Health IT 3Health News:Global Med Technologies(R), Inc.'s Division, Wyndgate Technologies(R), to Exhibit at 60th Annual AABB Conference 2Health News:Global Med Technologies(R), Inc.'s Division, Wyndgate Technologies(R), to Exhibit at 60th Annual AABB Conference 3Health News:Immune Proteins Warn of Early Lung Cancer 2Health News:Oridion Introduces New Smart Capnography System for Improved Patient Safety 2Health News:Oridion Introduces New Smart Capnography System for Improved Patient Safety 3Health News:Oridion Introduces New Smart Capnography System for Improved Patient Safety 4Health News:Makers of OTC Cough and Cold Medicines Announce Voluntary Withdrawal of Oral Infant Medicines 2Health News:Makers of OTC Cough and Cold Medicines Announce Voluntary Withdrawal of Oral Infant Medicines 3Health News:Experts Urge Businesses to 'Get Real' About Obesity Impact 2Health News:Experts Urge Businesses to 'Get Real' About Obesity Impact 3Health News:Experts Urge Businesses to 'Get Real' About Obesity Impact 4
For injecting viscoelastic to all meridians of the anterior chamber and to coat intraocular lenses. 27G x 7/8in (.40 x 22mm), angled 10mm from end....
Cannula tip is specially rounded, extra smooth for safe insertion through wound and manipulation in the anterior chamber. 27G x 7/8 in (.40 x 22mm)....
For injecting anesthetics into the muscle cone. 23G x 1 1/2 in (.60 x 38mm)...
... (Electronystagmography) is a complete vestibular diagnostic ... eye movements collected via electrodes. Its ... to use. Saccade, tracking and Slow ... interpretation is facilitated by graphic comparison ...
Medicine Products: